American Society of Hematology, 2025 (ASH) 7 - 9 December 2025

Etavopivat in Adolescents with Sickle Cell Disease: Emerging Safety and Efficacy Findings from the First Cohort of the Ongoing Phase 1/2 HIBISCUS Kids Study

Authors :

Adlette Inati¹, Bernhards Ogutu^2,3, E. Leila Jerome Clay⁴, Pavithra Dhayakar⁵, Kaming Lo^{6, Miguel Abboud⁷}

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Sickle Cell Disease

Congress oral presentation

Etavopivat

Are you a healthcare professional?